{
  "format": "listen-step-protocol@1",
  "kind": "module",
  "name": "Marqibo-type sphingomyelin liposomal vincristine",
  "tags": [
    "Liposome",
    "Literature recipe"
  ],
  "steps": [],
  "labItems": [
    {
      "id": "component-marqibo-sphingomyelin-liposomal-vincristine",
      "kind": "recipe",
      "afterStep": 0,
      "snapshot": {
        "id": "literature-marqibo-sphingomyelin-liposomal-vincristine",
        "kind": "recipe",
        "name": "Marqibo-type sphingomyelin liposomal vincristine",
        "category": "Liposome",
        "tags": [
          "Liposome",
          "Literature recipe"
        ],
        "steps": [],
        "materials": [
          {
            "name": "Sphingomyelin",
            "detail": "60 mol%"
          },
          {
            "name": "Cholesterol",
            "detail": "40 mol%"
          },
          {
            "name": "Vincristine sulfate",
            "detail": "5 mg in 31 mL in the reviewed product"
          }
        ],
        "tables": [
          {
            "id": "optisome",
            "name": "Sphingomyelin/cholesterol Optisome composition",
            "header": [
              "Component / parameter",
              "Value",
              "Context"
            ],
            "rows": [
              [
                "Sphingomyelin",
                "60 mol%",
                "Membrane lipid"
              ],
              [
                "Cholesterol",
                "40 mol%",
                "Membrane composition"
              ],
              [
                "Vincristine sulfate",
                "5 mg in 31 mL; 0.16 mg/mL",
                "Reviewed vial strength"
              ],
              [
                "Mean diameter",
                "Approximately 100 nm",
                "Reviewed formulation"
              ],
              [
                "Encapsulated vincristine",
                "More than 95%",
                "Reviewed formulation"
              ]
            ]
          }
        ],
        "tableChoices": {},
        "author": "Listen Step",
        "origin": {
          "type": "curated-literature",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
          "reviewedAt": "2026-11-09"
        },
        "source": {
          "citation": "Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).",
          "doi": "10.3390/pharmaceutics9020012",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
          "locator": "Table 1 and Section 3.1.6, Marqibo"
        },
        "review": {
          "status": "source-values-checked",
          "reviewedAt": "2026-11-09",
          "scope": "Literature composition only, not clinical manufacturing or administration guidance. Product indication and vial strength are context, not dosing instructions."
        },
        "createdAt": 1794182400000,
        "updatedAt": 1794182400000
      }
    }
  ],
  "materials": [
    {
      "name": "Sphingomyelin",
      "detail": "60 mol%"
    },
    {
      "name": "Cholesterol",
      "detail": "40 mol%"
    },
    {
      "name": "Vincristine sulfate",
      "detail": "5 mg in 31 mL in the reviewed product"
    }
  ],
  "source": {
    "citation": "Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).",
    "doi": "10.3390/pharmaceutics9020012",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
    "locator": "Table 1 and Section 3.1.6, Marqibo"
  },
  "review": {
    "status": "source-values-checked",
    "reviewedAt": "2026-11-09"
  }
}
